Cyclo Therapeutics Inc. (CYTH)
NASDAQ: CYTH
· Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM
Cyclo Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.83M | -5.98M | -4.34M | -5.64M | -4.77M | -4.64M | -5.01M | -4.98M | -4.25M | -3.45M | -2.77M | -2.79M | -3.86M | -3.6M | -4.04M |
Depreciation & Amortization | 2.18K | 2.18K | 2.18K | 4.82K | 4.82K | 4.82K | 4.82K | 4.87K | 5.13K | 4.74K | 4.74K | 4.21K | 4.21K | 4.86K | 3.55K |
Stock-Based Compensation | -17.81K | 365.86K | 173.22K | 257.77K | 202.04K | 185.44K | 91.67K | 215.52K | 119.3K | 144.02K | 147.74K | -206.86K | 305.83K | 271.31K | 50.3K |
Other Working Capital | 1.18M | 201.93K | -612.69K | 826.37K | 155.00 | 155.00 | -395.33K | 2.75M | 158.45K | 50.1K | -1.62M | 87.02K | -137 | -70 | -1.18M |
Other Non-Cash Items | -316.02K | 618.87K | 1.79M | 114.68K | -126.25K | -1.45M | -834.39K | -80.98K | 9K | 41.26K | -117.52K | 21.93K | 158.24K | 1.27M | -180.39K |
Deferred Income Tax | n/a | n/a | n/a | -61.76K | 126.25K | 1.45M | 834.39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 972.19K | 1.15M | -2.12M | 1.03M | 523.29K | 967.49K | 540.36K | 2.09M | 962.74K | -1.05M | -2.05M | 361.44K | 473.07K | -1.12M | -944.05K |
Operating Cash Flow | -8.19M | -3.85M | -6.18M | -4.29M | -4.04M | -3.48M | -4.37M | -2.75M | -3.18M | -4.36M | -4.83M | -2.61M | -3.03M | -4.44M | -4.93M |
Capital Expenditures | -3.85M | 3.85M | n/a | -2.42K | n/a | n/a | n/a | 15.09K | -10.49K | n/a | -4.6K | 22.5K | n/a | -22.5K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -2.42K | n/a | n/a | n/a | 4.81K | 28.76K | 10.58K | 13.92K | -12.17K | 6.82K | 16.84K | 3.33K |
Investing Cash Flow | n/a | n/a | n/a | -2.42K | n/a | n/a | n/a | 19.89K | 18.28K | 10.58K | 9.32K | 10.33K | 6.82K | -5.66K | 3.33K |
Debt Repayment | 8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.78K | n/a | -6.78K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.4K | 1.97M | -69.28K | 11.23M | 1.48K | 509.79K | 2.41M | -144.58K | n/a | n/a | n/a | n/a | n/a | 402.01K | 7.58M |
Financial Cash Flow | 8M | 1.97M | -69.28K | 11.74M | 5M | 3.41M | 3.74M | 6.78K | n/a | n/a | 6.78K | 10.77M | -1.78K | 402.01K | 7.58M |
Net Cash Flow | -193.8K | -1.87M | -6.25M | 7.44M | 960.28K | -73.65K | -628.24K | -2.75M | -3.16M | -4.35M | -4.81M | 8.17M | -3.02M | -4.04M | 2.66M |
Free Cash Flow | -12.04M | -3.85M | -6.18M | -4.3M | -4.04M | -3.48M | -4.37M | -2.73M | -3.19M | -4.36M | -4.83M | -2.59M | -3.03M | -4.46M | -4.93M |